Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants. Their new study, published online on July 1, 2021 in Cell Reports Medicine, shows that both CD4+ “helper” T… Read More »
Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021 • 4 days ago • 5 minute read • 126 Comments “There may be some brand recognition… Read More »
Through its COVID-19 vaccine partnership with the U.S. government, Moderna picked up nearly $ 1 billion in research aid. Now, it’s joining a list of other companies to take a supply order from the federal government. Under a deal worth up to $ 1.525 billion, Moderna agreed to deliver 100 million doses of its mRNA vaccine… Read More »
President Trump announced the deal during a media briefing on Tuesday. Moderna is one of several companies manufacturing the vaccine “at risk,” as the industry calls it, meaning the company is currently making the vaccine before it is approved. Clinical trials are currently underway to test whether it’s safe and effective. Under this contract, worth… Read More »